Find Your Next Asia Partnership in Tokyo at BIO Asia

The One-on-One Compass

On April 8-9, 2014, the BIO Asia International Conference will enter its eleventh year. This year, biopharma industry leaders will convene at the Grand Hyatt in Tokyo, Japan to make the cross border deals that will advance collaboration between Asia and the West. This event has become the premier customized partnering event for Western and Asian biopharma executives. According to JP Morgan healthcare specialist Scott Braunstein, Japan has become one of the most critical markets for pharma and biotech firms. Japan currently holds the spot for the second largest pharmaceutical market in the world.

Asian biopharmas at this year’s plenary sessions will include Acucela Inc., TaiGen Biotechnology Co., Ltd., Pfizer (Asia), Baxter (Japan), and Taiwan Liposome Company, Ltd. The speakers and the full descriptions for the 2014 panels can be viewed here. In addition, the following list of Asian biopharma companies will be available for One-on-One Partnering, with more being added daily:

Acucela, Inc.
Allergan Singapore Pte Ltd.
Asahi Kasei Corporation
ASLAN Pharmaceuticals Pte Ltd.
Astellas Pharma, Inc.Baxter
Beijing Fogangren Bio-Pharm Tech, Co., Ltd.
Chugai Pharmaceutical Co., Ltd.
Curadev Pharma Pvt Ltd.
Daiichi Sankyo, Inc.
Dong-A ST
Dr.Reddy’s Laboratories Ltd.
Eddingpharm
Fresenius Kabi Asia Pacific Ltd.
Generon (Shanghai) Corporation
GlaxoSmithKline
Global Health Innovative Technology Fund (GHIT Fund)
Golden Biotechnology Corporation
Hisamitsu Pharma
Hua Medicine
ICS Convention Design, Inc.
Ildong Pharmaceutical Co., Ltd.
JCR Pharmaceuticals Co., Ltd.
Jeil Pharmaceutical
JCR Pharma
JT Pharma
Kissei Pharmaceutical Co., Ltd.
Lilly China Research and Development Co., Ltd.
Lundbeck Research China
Mitsubishi Tanabe Pharma Corporation
Mitsui Chemicals Inc.
MSD K.K.
Nippon Kayaku Co., Ltd.
Ono Pharmaceutical Co., Ltd.
Pluristem Therapeutics, Inc.
ReqMed Company, Ltd.
Sosei Co. Ltd.
TaiGen Biotechnology Co., Ltd.
Taiho Pharmaceutical Co., Ltd.
Taiwan Liposome Company Co., Ltd. (TLC)
Takeda Pharmaceutical Co., Ltd.
Tanaka International, LLC
Tech Manage Corp.
Teva Pharmaceutical Industries Ltd.
Tokyo Stock Exchange, Inc.

There is growing interest in U.S. partnerships by Japanese biopharmas, as evident in several recent deals including Ajinomoto’s $175 million acquisition of San Diego-based Althea Technologies last year. One reason why Japan has become popular among Western biotech and pharma companies is the direct access available in Japan to end markets. Leading biotech companies such as Celgene can sell their products straight into the Japanese market and enjoy overwhelming success.

Registration for the BIO Asia International Conference is open, and BIO’s One-on-One PartneringTM System has launched. Don’t miss this chance to capitalize on the growing opportunities for collaboration available in Asia- register today!

The One-on-One Compass  |  Email This Post  |  Printer Friendly
Tags: , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>